Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Laura Fogliatto"'
Autor:
Marcia Torresan Delamain, Ana Carolina Ferreira Cardoso, Fernando Vieira Pericole, Sérgio Shusterschitz da Silva Araújo, Laura Fogliatto, Marcia Higashi, Juliana Pereira, Roberto Luiz da Silva, Gustavo Werutsky, Patrícia de Paulo Giacon Radtke, Marco Aurélio Salvino, Vivienne Castilho
Publikováno v:
Oncology and Therapy, Vol 12, Iss 3, Pp 585-598 (2024)
Abstract Introduction RTXM83, a biosimilar of rituximab, was approved after physicochemical, functional, non-clinical, and clinical studies demonstrated their similarity; these studies included RTXM83-AC-01-11, a multicentric double-blind internation
Externí odkaz:
https://doaj.org/article/8d68eaeacb15499abfd7b18e99202271
Autor:
Claire Harrison, David Ross, Laura Fogliatto, Lynda Foltz, Lambert Busque, Zhijian Xiao, Florian Heidel, Michael Koehler, Giuseppe A. Palumbo, Massimo Breccia, Norio Komatsu, Keita Kirito, Blanca Xicoy Cirici, Joaquín Martinez-Lopez, Alicia Rovó, Cheryl Petruk, Catalin Bobirca, Laura Mirams, Abigail Mcmillan, Gavin Harper, Jean-Jacques Kiladjian
Publikováno v:
HemaSphere, Vol 7, p e1488093 (2023)
Externí odkaz:
https://doaj.org/article/8c805b06e4e04c988f869a53fb161acc
Autor:
Verena Pfister, Fernanda de Morais Marques, Flavia Parra, Mihoko Yamamoto, Matheus Vescovi Gonçalves, Leila Perobelli, Valeria Buccheri, Raphael Bandeira, Sergio Fortier, Alita Azevedo, Rodrigo Santucci, Marcelo Bellesso, Laura Fogliatto, Glaciano Ribeiro, Germison Silva Lopes, Maura Ikoma, Vera P. Figueiredo, Irene Gyongyver H Lorand Metze, Carlos Sérgio Chiattone, Celso Arrais‐Rodrigues
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 698-706 (2022)
Abstract Chronic lymphocytic leukaemia (CLL) has a highly variable clinical course. In addition to biological factors, socioeconomic factors and health system characteristics may influence CLL outcome. Data from the Brazilian Registry of CLL were ana
Externí odkaz:
https://doaj.org/article/e2bb3cfe9208400a99fa243222daaeb6
Autor:
Carsten U. Niemann, Farrukh T. Awan, Laura Fogliatto, Eugene Nikitin, Olga Samoilova, Adel Habib, Kayhan Foroutanpour, Nataliya Kuptsova-Clarkson, Stephen Opat
Publikováno v:
HemaSphere, Vol 6, Iss 10, p e780 (2022)
Externí odkaz:
https://doaj.org/article/b2ad5d4541f54b63afd90e243fe5c891
Autor:
Fernanda Salles Seguro, Carolina Maria Pinto Domingues Carvalho Silva, Carla Maria Boquimpani de Moura, Monika Conchon, Laura Fogliatto, Vaneuza Araujo Moreira Funke, André Abdo, Ariane Vieira Scarlatelli Macedo, Marilia Harumi Higushi dos Santos, José Francisco Kerr Saraiva
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 2, Pp 191-200 (2021)
This manuscript summarizes the results of the consensus meeting composed of hematologists and cardiologists to establish recommendations for the prevention and follow-up of cardiovascular (CV) risk in patients with chronic myeloid leukemia (CML) trea
Externí odkaz:
https://doaj.org/article/6172ec3bee5447e2843ae019ef078a76
Autor:
Miguel Pavlovsky, Daniel Cubero, Gladys Patricia Agreda-Vásquez, Alicia Enrico, Maria J. Mela-Osorio, Jorge Armenta San Sebastián, Laura Fogliatto, Roberto Ovilla, Oscar Avendano, Gerardo Machnicki, Paula Barreyro, Damila Trufelli, Pamella Villanova
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEReal-world evidence on non-Hodgkin lymphoma (NHL) management in Latin America is currently lacking. The objective of this study was to describe treatment characteristics and outcomes of NHL in Latin America.METHODSA total of 2,967 patients wit
Externí odkaz:
https://doaj.org/article/5d86b96d9bdb43e3a68482e339379925
Autor:
Laura Fogliatto, Kamila Castro Grokoski, Yuri Machado Strey, Tito Vanelli, Christina Garcia da Silva Fraga, Marines Bizarro Barra, Fernanda Correa Pinto, Israel Bendit, Claúdia Giuliano Bica
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 41, Iss 1, Pp 50-56 (2019)
Background: Diffuse large B-cell lymphoma, among non-Hodgkin lymphomas, is one of the most frequent subtypes. Clinical laboratory data and post-treatment outcomes are scarce in the Brazilian population. Objective: The main objective of this retrospec
Externí odkaz:
https://doaj.org/article/92a4beebc594480c8266bf82718ee785
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 36, Iss 1, Pp 54-59 (2014)
Treatment of chronic myeloid leukemia with BCR-ABL tyrosine kinase inhibitors requires full adherence in order to maximize the likelihood of achieving optimal responses, and to minimize healthcare costs. In this article, we review some of the methods
Externí odkaz:
https://doaj.org/article/cb7bfdef5ff446f39ff1a60cd927be08
Autor:
Franceli Carvalho, Joice Zuckermann, Alessandra Paz, Gustavo Fischer, Liane Esteves Daudt, Lisandra Della Costa Rigoni, Lúcia Silla, Laura Fogliatto, Simone Martins de Castro, Diogo André Pilger
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 11, Iss 1 (2016)
Background: Tyrosine kinase inhibitors (TKIs) were the first drugs to use an intracellular signaling molecule as a therapeutic target. Unresponsiveness to TKIs limits therapeutic options, making allogeneic hematopoietic stem cell transplantation (HSC
Externí odkaz:
https://doaj.org/article/9dc6274f87df428bb92396294a453419
Autor:
Rosane I. Bittencourt, Flavo B. Fernandes, Alessandra A. Paz, Laura Fogliatto, Cláudia C. Astigarraga, João R. Friederich, Denise S. Leugheur, Lucia M. R. Silla
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 30, Iss 3, Pp 202-207 (2008)
A leucemia mielóide aguda (LMA) representa uma preocupação para os especialistas, porque perfaz um percentual alto das leucemias no adulto e o sucesso terapêutico ainda é insatisfatório. A partir do ano 2000, o Serviço de Hematologia do Hospit
Externí odkaz:
https://doaj.org/article/7112eb2d6b13438e92d80d462f88cfda